Group 1 - The core viewpoint highlights the transformation of Baile Pharmaceutical into an innovative drug developer, emphasizing the importance of innovation in corporate growth [1] - Baile Pharmaceutical's research on the anti-tumor ADC molecule BL-B01D1 has spanned ten years, with significant clinical data released in June 2023, leading to a surge in the company's stock price [1] - The shift in the industry landscape in Sichuan from traditional sectors to emerging industries like photovoltaic and biomedicine reflects the region's economic upgrade [1] Group 2 - As of this year, Sichuan has 20 listed companies in the biomedicine sector, indicating a rise in both quantity and quality of the industry [2] - The Chengdu-Chongqing region's biomedicine cluster has been recognized in the Ministry of Industry and Information Technology's 2024 list of advanced manufacturing clusters, showcasing the optimization of Sichuan's industrial structure [2] - The number of national-level specialized and innovative "little giant" enterprises in Sichuan has increased from 74 in 2020 to 486 in 2024, indicating a robust growth in the region's innovation capabilities [2]
科创力量正改变人们对四川产业的传统印象
Si Chuan Ri Bao·2025-09-08 22:27